SCHOTT Introduces Cartridge Design for High-Speed Filling - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

SCHOTT Introduces Cartridge Design for High-Speed Filling


At INTERPHEX last month, SCHOTT Pharmaceutical Systems introduced glass cartridges that have been developed specifically for the use on high-speed filling lines. The new design enables quicker processing and reduces overfill losses, the company said in a press release.

More companies are using high-speed filling lines to meet the growing demand for insulin products, and the trend is expected to spread to other products, such as dental cartridges. High-speed filling lines, which can fill up to 600 cartridges per minute, have special quality requirements for cartridges. SCHOTT, in partnership with lead customers, translated these process requirements into a new product design that includes defining the neck specification with respect to straightness and cosmetic defects. Manufacturing for the cartridges will be piloted in St. Gallen, Switzerland, where SCHOTT’s competence center for cartridges is based and from where modifications to manufacturing will be managed globally.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
32%
Breakthrough designations
8%
Protecting the supply chain
40%
Expedited reviews of drug submissions
8%
More stakeholder involvement
12%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here